Showing results (1-10 of 201) with videos related to
Sort By:
Pageof 21
Alzheimer'S Research & Therapy|July 1, 2010
Pro: Can biomarkers be gold standards in Alzheimer's disease?Reisa Sperling, Keith JohnsonContinuum (Minneapolis, Minn.)|April 6, 2013
Biomarkers of Alzheimer disease: current and future applications to diagnostic criteriaReisa Sperling, Keith JohnsonNeuron|December 3, 2014
The evolution of preclinical Alzheimer's disease: implications for prevention trialsReisa Sperling, Elizabeth Mormino, Keith JohnsonAnnals of the New York Academy of Sciences|April 7, 2007
Functional MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer's diseaseReisa SperlingNeurobiology of Aging|November 15, 2011
Potential of functional MRI as a biomarker in early Alzheimer's diseaseReisa SperlingThe Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|January 20, 2007
The role of neuroimaging in elucidating delirium pathophysiologyDavid C Alsop, Michael A Fearing, Keith Johnson, et al.Cell|October 17, 2023
Accelerating Alzheimer's therapeutic development: The past and future of clinical trialsAdam L Boxer, Reisa SperlingHuman Brain Mapping|December 29, 2016
Epicenters of dynamic connectivity in the adaptation of the ventral visual systemVesna Prčkovska, Willem Huijbers, Aaron Schultz, et al.Frontiers in Aging Neuroscience|February 17, 2022
Longitudinal Trajectories of Participant- and Study Partner-Rated Cognitive Decline, in Relation to Alzheimer's Disease Biomarkers and Mood SymptomsCatherine E Munro, Rachel Buckley, Patrizia Vannini, et al.Journal of Molecular Neuroscience : MN|August 13, 2016
A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer's DiseaseRachel F Buckley, Victor L Villemagne, Colin L Masters, et al.Pageof 21